MENU
STOK
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Stoke Therapeutics (STOK) Ownership - Who owns Stoke Therapeutics?
Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine... Show more
Profile
Industry
N/A
Address
45 Wiggins Avenue
Phone
+1 781 430-8200
Employees
110
Web
https://www.stoketherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
319.6M
P/E Ratio
N/A
Total Cash
216.9M
Projected Growth
N/A
Total Debt
2.32M
Revenue
36.56M
Risk (Beta)
1.51
Dividend Yield
N/A
Total Cash/Share
4.01
Total Debt/Equity
N/A
Revenue/Share
0.68 USD as % of share price
Fundamentals
STOK
Capitalization
320M
P/E Ratio
N/A
Risk (Beta)
1.51
Dividend Yield
N/A
Total Cash
217M
Total Cash/Share
4.01
Total Debt
2.32M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.68%
Revenue
36.6M
ROE
N/A
Book Value
229M
P/B Ratio
1.40
Cash Flow
N/A
Earnings
-1.65
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
5.81
Current Revenue Per Employee
176671.88
Dividends Per Share - Security
N/A
EBITDA
-99.2M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-35.60
Shares Held By Institutions
739M
Shares Outstanding - Current
54.1M
Total Liabilities
42.5M
Total Volume MTD
N/A
Value
1
Gain YTD
-46.510
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company, which engages in the research and development of treatments for genetic diseases.
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
45 Wiggins Avenue
Phone
+1 781 430-8200
Employees
110
Web
https://www.stoketherapeutics.com